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LETTERS
C. psittaci, C. pneumoniae, C. abortus, 
and C. suis (6–10). To our knowledge, 
this member of the family Chlamydi-
aceae has been seen in amphibians, but 
not in other vertebrate hosts. The 16S 
rRNA analysis showed this taxon to be-
long to a clade with Candidatus Clavo-
chlamydia salmonicola, a taxon found 
in fi sh. The phylogenetic position of the 
novel taxon in the family Chlamydia-
ceae thus roughly refl ects the phyloge-
netic relation between the host species, 
providing evidence for host–bacterium 
co-evolution in the family Chlamydi-
aceae.
 Although the results obtained 
are not conclusive with regard to the 
pathogenic potential of this novel ge-
nus and species of Chlamydiales, we 
were not able to attribute the clinical 
signs to any known disease. We there-
fore suggest that we discovered a nov-
el bacterial taxon with possible con-
siderable impact on amphibian health.
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Novel Variant 
of Beilong 
Paramyxovirus 
in Rats, China
To the Editor: In 2003, two 
cDNA strands were identifi ed in a 
human mesangial cell line during 
experimental screening for genes 
upregulated by angiotensin II (1). 
Sequence analysis showed that the 
strands were homologous to the matrix, 
fusion, and phosphoprotein genes 
of paramyxoviruses, suggesting the 
possibility of a novel paramyxovirus 
(2,3). Subsequent research found that 
these sequences, believed to originate 
from human kidney mesangial cell 
lines, were not amplifi able from such 
cell lines or human kidney samples 
but were amplifi able from a rat kidney 
mesangial cell line (4). Isolation and 
complete genome sequencing of the 
virus confi rmed that it was a novel 
paramyxovirus of the subfamily 
Paramyxovirinae, named Beilong 
virus (BeV). 
BeV is most closely related to 
J virus, discovered in autoculture 
of kidney tissue from a moribund 
house mouse, and Tailam virus from 
Sikkim rats (5,6). Because J virus and 
Tailam virus were found to originate 
in rodents and BeV was amplifi able 
from a rat kidney mesangial cell 
line, we hypothesized that BeV was 
a novel paramyxovirus originating 
in rats. To test this hypothesis, we 
conducted a territorywide molecular 
epidemiologic study of rats and other 
mammals to evaluate this novel 
paramyxovirus.
We tested 4,130 samples from 
1,398 animals collected from various 
locations in Hong Kong, People’s 
Republic of China, during September 
2008–August 2009 (Table). These 
included 480 kidney, spleen, 
respiratory swab, and anal swab 
samples from 120 asymptomatic rats 
(105 brown rats [Rattus norvegicus] 
and 15 black rats [R. rattus]). To 
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prevent cross contamination, we used 
disposable scalpels, decontaminated 
the work surface, and used sterile 
gloves for each tissue sample. We 
performed RNA extraction and 
reverse transcription PCR by using 
strategies we previously published for 
discovery and epidemiologic study of 
paramyxoviruses (6–9).
We performed BeV screening 
by PCR amplifi cation of a 440-
bp fragment of the large (L) gene, 
located at the 5′ end of the genome 
and used specifi c primers (LPW9739
G G A G G AT T C C C T C ATA G A G
AA-3′ and LPW9741 5′-CTCATAT
GTATTTACATTTAAACCA-3 ′) . 
The PCR mixture (25 μL) contained 
cDNA, PCR buffer (10 mmol/L 
Tris-HCl, pH 8.3, 50 mmol/L KCl, 3 
mmol/L MgCl2, and 0.01% gelatin), 
200 μM of each dNTP, and 1.0 units of 
Taq polymerase (Applied Biosystems, 
Foster City, CA, USA). The mixtures 
were amplifi ed in 60 cycles at 94°C for 
1 min, 48°C for 1 min, and 72°C for 1 
min; and a fi nal extension at 72°C for 
10 min in an automated thermal cycler 
(Applied Biosystems).
BeV in the positive samples was 
confi rmed by amplifying a 318-bp 
fragment of the nucleocapsid (N) 
gene of BeV, located at the 5′ end of 
the genome; by using specifi c primers 
(LPW10723  5′-TATATGGTTGAGAT
YCTNATHGA-3′ and LPW10408   5′ -
CCATKGCRTAGCTCCADAG-3′) 
and experimental conditions described 
above. We confi rmed the specifi cities 
of the primers by testing samples 
positive for Tailam virus (6), which all 
showed negative results.
Results of reverse transcription 
PCR for a 440-bp fragment in the 
large gene of BeV were positive for 40 
kidney and 9 spleen samples from 43 
rats (40 brown rats and 3 black rats). 
Sequencing and phylogenetic analysis 
showed 6–13 base differences between 
the sequences and the corresponding 
region in the large gene of BeV 
(GenBank accession no. NC_007803), 
suggesting that this is a novel variant 
of BeV in our locality. 
Results of reverse transcription 
PCR for a 318-bp fragment in the 
N gene of BeV were positive in the 
same 40 kidney and 9 spleen samples 
from the 43 rats. Sequencing and 
phylogenetic analysis showed 1–9 base 
differences between the sequences 
and the corresponding region in the N 
gene of BeV. The kidney and spleen 
samples were positive in 4 brown rats 
and 2 black rats. The L and N gene 
sequences amplifi ed from the kidney 
and spleen samples were identical in 
5 of the 6 rats. However, in 1 brown 
rat, L and N gene sequences from the 
kidney and spleen samples differed 
by 4 and 6 bases, respectively, 
suggesting the possibility of 2 strains 
of BeV in the same rat. None of the 
samples from the other mammals 
were positive. The authenticity of the 
results was supported by identical 
results from 2 independent genes of 
the BeV genome, sequence variations 
in the L and N genes from the positive 
samples, and negative results from all 
other mammals tested.
This study suggests that BeV 
and its variants are endemic in 
brown rats and black rats, but it is 
not known whether transmission is 
vertical or horizontal. Detection of 
BeV and Tailam virus in kidney and 
spleen samples, but not respiratory or 
anal swabs, suggested that they are 
probably systemic viruses excreted 
in urine. Phylogenetic and genomic 
evidence support the grouping of 
BeV, Tailam virus, and J virus into 
a new genus of Paramyxovirinae. 
Distinctly, the genomes of all 3 
viruses contain 8 genes (3′ -N-P/V/C-
M-F-SH-TM-G-L-5′). We speculate 
that the ancestor of these closely 
related paramyxoviruses infected the 
common ancestor of rats and mice, 
with subsequent co-evolution and 
divergence with the host.
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Table. Mammals screened for Beilong virus, People’s Republic of China, September 
2008–August 2009 
Animal Sample type* 
Bats, n = 502 Throat swab, rectal swab  
Cats, n = 130 Nasal swab, rectal swab, urine, blood 
Cattle, n = 100 Nasal swab, rectal swab, liver, buffy coat, plasma 
Dogs, n = 149 Nasal swab, rectal swab, urine, blood 
Hamsters, n = 49 Throat swab, intestinal swab, kidney 
Pigs, n = 100 Nasal swab, rectal swab, liver, blood 
Wild urban rodents, n = 120 Rectal swab, throat swab, rectal swab, kidney, spleen 
Wild rural rodents, n = 248 Throat swab, rectal swab 
*All sample types listed for each animal were collected except wild rodents: 237 throat swab and 
246 rectal swab samples were collected from 248 wild rodents. 
1These authors contributed equally to this 
article.
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Pneumococcal 
Serotype–specifi c 
Unresponsiveness 
in Vaccinated Child 
with Cochlear 
Implant 
To the Editor: Approximately 
100,000 persons worldwide have 
received cochlear implants for hearing 
loss, and more children now receive 
them than ever (1). Such children 
have a >30-fold increased risk for 
pneumococcal meningitis than the 
background rate (1,2). During 2006–
2010, children born in the United 
Kingdom were offered the 7-valent 
pneumococcal conjugate vaccine 
(PCV7) at 2, 4, and 13 months of age 
(3). Those at high risk for invasive 
pneumococcal disease (IPD) were 
additionally offered the 23-valent 
pneumococcal polysaccharide vaccine 
(PPV23) at 2–5 years (3). We 
describe a fully vaccinated child 
with a cochlear implant in whom 
recurrent pneumococcal meningitis 
developed, caused by a vaccine 
serotype (i.e., vaccine failure). The 
child continues to have nonprotective 
antibody concentrations against the 
infecting serotype, despite further 
pneumococcal vaccination.
A previously healthy, appro-
priately vaccinated 23-month-old 
girl (Table) had a cochlear device 
implanted in the right ear after 
receiving (through the universal 
newborn hearing screening program) 
a diagnosis of profound, bilateral, 
sensorineural deafness. Two weeks 
later, she exhibited fever, lethargy, and 
drowsiness. On hospital admission, 
she had a peripheral blood leukocyte 
count of 19.3 × 109 cells/L, a 
neutrophil count of 17.0 × 109 cells/L, 
and C-reactive protein level 75 mg/L. 
Meningitis was diagnosed, and she 
received intravenous ceftriaxone but 
was too ill for a lumbar puncture. 
Blood cultures subsequently grew fully 
sensitive Streptococcus pneumoniae, 
later confi rmed as serotype 4 by the 
national reference laboratory. She was 
discharged after 14 days of receiving 
intravenous antimicrobial drugs 
without complications.
At 24 months, she received a 
fourth dose of PCV7. Blood tests 1 
month later showed good antibody 
responses to 6 PCV7 serotypes but not 
to serotype 4, which did not reach the 
putative protective level of >0.35 μg/
mL antibody threshold (Table). At 28 
months, she received 1 dose of PPV23 
per national guidelines (3). Four 
months later, she was brought to the 
hospital with fever, rigors, drowsiness, 
and vomiting. Blood tests showed a 
leukocyte count of 24.4 × 109 cells/L, 
neutrophil count of 21.6 × 109 cells/L, 
and C-reactive protein level of 272 
mg/L. Lumbar puncture performed 
the next day showed 890 leukocytes/
mL (predominantly polymorphs), 
cerebrospinal fl uid glucose level <1.1 
mmol/L, protein level of 1.0 g/L, 
gram-positive diplococci on Gram 
staining, and positive PCR results for 
pneumococci, although cerebrospinal 
fl uid culture was negative.
A blood culture grew fully 
sensitive S. pneumoniae, also 
confi rmed by the national reference 
laboratory as serotype 4. She 
recovered after receiving intravenous 
ceftriaxone and oral rifampin for 2 
weeks, followed by 4 weeks of oral 
amoxicillin and rifampin. She then 
received prophylactic oral penicillin 
for maintenance. Subsequently, an 
abdominal ultrasound confi rmed 
the presence of a spleen, and her 
immunoglobulin concentrations were 
in the normal range. At 35 months, she 
received another dose of PCV7, and a 
blood test 1 month later showed variable 
but high responses to 6 of the PCV7 
serotypes and no response to serotype 
4 (Table). Moreover, nasopharyngeal 
swab specimens, obtained when 
the patient was 39 months old and 
receiving penicillin prophylaxis, were 
positive for serotype 4.
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